Delivery Order SPE2DB24D2109-SPE2DB25FHWHS

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,470.38 firm fixed-price delivery order is for DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,630.71 firm fixed-price delivery order is for DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,392.26 firm fixed-price delivery order is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,495.82 firm fixed-price delivery order covers the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 29, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is a $5,461.27 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a period of performance through December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,632.03 firm-fixed-price delivery order contract is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,059.74 firm fixed-price delivery order is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award summarized is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $107,086.31 Firm Fixed Price contract covers the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, with a period of performance through July 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,695.98, is for the delivery of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through July 19, 2024 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,465.71 firm fixed-price delivery order is for the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB25FHWHS
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,221.69 Firm Fixed Price Delivery Order covers the supply of DOVATO 50-300 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:56 AM